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Introduction
Atherosclerosis involves the progressive accumulation of lipids, 
immune cells, and ECM in the vessel wall, which can decrease 
blood fl  ow or rupture to cause acute thrombosis. Endothelial cell 
dysfunction is the key initiating event in atherogenesis, resulting in 
decreased fl  ow-induced dilation and infl  ammatory gene expression 
(Ross, 1999). Activated endothelium recruits monocytes, which 
differentiate into macrophages. Elevated permeability of the endo-
thelium is believed to allow entry of lipoproteins into the vessel 
wall, which become oxidized and propagate endothelial dysfunc-
tion (Steinberg, 1997). Macrophages engulf low-density lipo-
protein (LDL) and other lipoproteins and become foam cells, which 
can be visualized as fatty streaks in the vessel wall. In the continued 
presence of high LDL cholesterol and oxidant stress, fatty streaks 
progress to advanced atherosclerotic plaques (Ross, 1999).
Despite the systemic nature of most atherogenic stimuli, 
atherosclerosis is a focal disease affecting discrete regions of the 
vasculature, such as vessel curvatures and bifurcations. These 
regions are characterized by complex fl  ow patterns. including 
fl  ow reversal, fl  ow gradients, secondary fl  ows with rapid changes 
in fl  ow direction, and, in some regions, turbulence (VanderLaan 
et al., 2004). We group all of these fl  ow patterns under the rubric 
of disturbed fl  ow. Endothelial cells sense the force of fl  owing 
blood, termed shear stress, and different blood fl  ow patterns reg-
ulate endothelial behavior. Regions of blood vessels exposed to 
undisturbed, unidirectional laminar fl  ow  (henceforth  termed 
laminar fl  ow) are protected from atherosclerosis, and in vitro 
prolonged laminar fl  ow stimulates expression of athero-protective 
genes (Traub and Berk, 1998; Brooks et al., 2004). By contrast, 
disturbed flow patterns stimulate proatherosclerotic events, 
  including increased monolayer permeability; decreased anti-
oxidant capacity; and enhanced expression of proinfl  ammatory 
genes, such as ICAM-1, VCAM-1, and monocyte chemotactic 
protein-1 (MCP-1; Jo et al., 1991; De Keulenaer et al., 1998; 
Phelps and DePaola, 2000; Brooks et al., 2004). The correlation 
between fl  ow patterns and endothelial monolayer permeability 
has recently been demonstrated in vivo, where vascular permea-
bility is inversely proportional to time-average shear stress and 
correlated with increased fl  ow oscillation and fl  ow gradients 
(Himburg et al., 2004; LaMack et al., 2005). Interestingly, onset 
of laminar shear stimulates many of the same responses as dis-
turbed shear; however, in laminar shear, these events are down-
regulated as cells adapt, whereas in disturbed shear, they are 
sustained. Thus, failure to adapt is thought to be critical for 
  responses to disturbed shear (Orr et al., 2006).
The molecular mechanisms involved in fl  ow-induced endo-
thelial permeability are unknown. Although vesicular transport and 
transcellular channels may contribute to endothelial   permeability, 
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to be crucial in atherogenesis because it allows 
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paracellular pore formation is most likely the major pathway for 
macromolecule transport across arterial endothelium (Ogunrinade 
et al., 2002). Paracellular permeability is limited by cell–cell 
interactions, especially those in tight junctions (TJs). Multiple 
molecular mechanisms implicated in regulation of endothelial 
paracellular permeability include changes in gene expression, 
phosphorylation of junctional components, myosin-dependent 
contractility, and stability of cortical actin (Ogunrinade et al., 
2002). Many signaling pathways regulate permeability, most 
of which affect cortical actin or myosin (Yuan, 2002). Actin 
remodeling is regulated by the Rho family of small GTPases, 
including Rho, Rac, and Cdc42 (Jaffe and Hall, 2005). The p21-
activated kinase (PAK) family of Ser/Thr kinases is important 
for Rac and Cdc42-induced cytoskeletal remodeling, affecting 
both actomyosin contractility and the stability of actin fi  laments 
(Bokoch, 2003). Recently, PAK was shown to stimulate para-
cellular pore formation and increased endothelial cell perme-
ability in response to a wide range of cellular stimuli (Stockton 
et al., 2004). PAK-mediated permeability responses require the 
localization of active PAK to cell–cell junctions, where PAK 
stimulates the phosphorylation of myosin light chain to induce 
contractility (Stockton et al., 2004). In addition, PAK can also 
promote paracellular pore formation by phosphorylating VE-
cadherin, which results in its arrestin-dependent internalization 
(Gavard and Gutkind, 2006). PAK contains multiple domains 
that bind scaffolding proteins, such as Nck and Grb2, capable of 
regulating PAK localization (Lu et al., 1997; Puto et al., 2003). 
Interestingly, both PAK localization to cell–cell junctions and 
PAK-mediated permeability were inhibited with a cell-permeable 
peptide corresponding to the Nck-binding sequence of PAK 
(Stockton et al., 2004).
Shear stress activates the integrin family of ECM receptors, 
and new integrin ligation mediates effects of fl  ow on Rac, Cdc42, 
and Rho activity (Jalali et al., 2001; Tzima et al., 2001, 2002, 
2003). Flow-induced GTPase regulation mediates cell alignment 
in the direction of fl  ow and stimulates the transcription factor 
NF-κB, which is important for expression of infl  ammatory genes 
in the endothelium (Tzima et al., 2002). The idea that integrin 
  ligation mediates these effects suggested that alterations in the 
subendothelial matrix composition would affect which integrins 
become ligated, resulting in differential signaling in response to 
fl  ow. Indeed, shear stress activates NF-κB when endothelial cells 
are plated on a fi  bronectin (FN) or fi  brinogen matrix, but not 
when cells are plated on collagen or laminin. Furthermore, FN 
and fi  brinogen were deposited at sites of disturbed fl  ow in vivo, 
which correlated with expression of NF-κB target genes (Orr 
et al., 2005). These results suggest that matrix remodeling plays 
a causal role in atherogenesis. In this work, we investigate the role 
of fl  ow and ECM in endothelial permeability in atherogenesis.
Results
Flow stimulates matrix-speciﬁ  c 
PAK activation and localization 
to cell–cell junctions
The N terminus of PAK contains a Rac/Cdc42 binding domain 
that overlaps an autoinhibitory domain (AID) such that binding 
of active GTPases alleviates an inhibitory interaction between 
the AID and the C-terminal kinase domain (Bokoch, 2003). 
PAK activation results in autophosphorylation at multiple sites 
(Gatti et al., 1999; Chong et al., 2001), including Ser141 at 
the end of the AID. Phosphorylation of this residue prevents the 
  interaction of the AID with the kinase domain to maintain the 
active conformation. Flow-induced integrin signaling activates 
both Rac and Cdc42 (Tzima et al., 2002, 2003), suggesting that 
PAK might be activated. Using PAK Ser141 phosphorylation as 
a marker, bovine aortic endothelial (BAE) cells were examined. 
Cells were plated for 4 h on coverslips coated with either FN or 
diluted matrigel (MG), which, under these conditions, adsorbs 
to the glass as a thin layer similar to FN. MG was used as a 
model for normal basement membrane proteins. We found that 
fl  ow stimulated biphasic PAK activation on FN; however, no 
signifi  cant activation occurred in cells on MG (Fig. 1 A). Collagen 
also failed to support PAK activation under these conditions 
(unpublished data). Immunofl  uorescence staining showed that 
activated PAK localized to cell–cell borders (Fig. 1 B). No 
  major changes in cell–cell junctions themselves were noted on 
this time scale (see Fig. 4). Consistent with previous results 
(Stockton et al., 2004), this localization was abrogated by the 
addition of a cell-permeant peptide that blocks the binding of 
PAK to Nck (unpublished data).
Responses to the onset of laminar shear are transient but 
otherwise resemble events triggered by disturbed fl  ow (Orr 
et al., 2006). We therefore determined PAK activity in endothelial 
cells exposed to different fl  ow patterns for longer times. BAE 
cells plated on FN were stimulated for 24 h with fl  ow profi  les 
derived from the athero-protective common carotid artery 
(CCA) or the athero-prone internal carotid sinus (ICS; Fig. 1 C; 
Gelfand et al., 2006). Matrix specifi  city was not determined in 
this assay because cell-derived matrices deposited over this 
  extended time course could affect signaling responses. Consis-
tent with the adaptation to fl  ow hypothesis, cells stimulated 
with ICS fl  ow show elevated PAK phosphorylation compared 
with cells stimulated with CCA fl  ow (Fig. 1 D).
Matrix-dependent PAK signaling regulates 
ﬂ  ow-induced endothelial permeability
Because PAK regulates permeability of endothelial monolayers 
(Stockton et al., 2004; Gavard and Gutkind, 2006), we tested 
whether matrix-specifi  c PAK activation correlates with permea-
bility. To assay fl  ow-mediated endothelial cell permeability, we 
developed a novel transwell assay that used a modifi  ed cone and 
plate device adapted to 75-cm transwell chambers (Fig. 2 A). 
Using this system, we applied shear to endothelial cell mono-
layers and assessed the movement of a tracer across the fi  lter. 
Membranes were then fi  xed and stained to ensure that no cell 
loss occurred during the assay. Consistent with previous results, 
we found that laminar fl  ow transiently increased endothelial 
cell permeability, which returned to baseline by 4 h (Fig. 2 B).
To determine whether these effects are matrix specifi  c, 
BAE cells were plated on either FN or diluted MG for 4 h. Endo-
thelial cells formed a complete monolayer with both adherens 
junctions and TJs as assessed by β-catenin and ZO-1 staining 
but deposited very little endogenous matrix (Fig. S1, available PAK MEDIATES PERMEABILITY IN ATHEROSCLEROSIS • ORR ET AL. 721
at http://www.jcb.org/cgi/content/full/jcb.200609008/DC1). 
Onset of fl  ow triggered a greater increase in permeability in 
cells on FN compared with MG or collagen IV (Fig. 3 A). In 
  addition, the low level of permeability in cells on MG was 
  enhanced in a dose-dependent manner when overlaid with FN 
(Fig. 3 B). Matrix proteins alone without cells did not differen-
tially affect permeability (Fig. S2).
To test whether PAK is involved in fl  ow-induced permea-
bility, cells were either transfected with a construct encoding 
the PAK AID or treated with a cell-permeant peptide that con-
tains the Nck-binding sequence from PAK. This peptide was 
previously shown to mimic the dominant-negative effects of 
  kinase-dead PAK, including inhibition of endothelial permea-
bility (Kiosses et al., 2002; Stockton et al., 2004). The peptide 
blocked the fl  ow-induced increase in permeability by  80%, 
whereas an inactive control peptide containing mutations in key 
proline residues involved in Nck binding (Kiosses et al., 1999) 
had no effect (Fig. 3 C). Though transfection effi  ciency with the 
PAK AID was  50%, the decrease in fl  ow-induced permeabil-
ity approached 50%, indicating that it is also highly effective 
(Fig. 3 D). In addition to HRP, Alexa 488–labeled BSA was also 
used to determine fl  ow-induced permeability. Absolute permea-
bility to both BSA and HRP were similar (Fig. 3, A and E), and 
both showed sensitivity to PAK inhibition (Fig. 3 E).
Disturbed fl  ow is known to increase permeability com-
pared with steady or arterial fl  ow patterns (Phelps and DePaola, 
2000). To confi  rm these results in our system, BAE cells on 
FN were exposed to CCA or ICS fl  ow for 4 h, and permeability 
was assessed. ICS fl   ow increased monolayer permeability 
nearly twofold compared with CCA fl  ow (Fig. 3 F). Immuno-
fl  uorescence revealed that active PAK was localized to cell–
cell junctions after 4 h of ICS fl  ow but not after CCA fl  ow 
(unpublished data). The blocking peptide also inhibited perme-
ability induced by ICS fl  ow (Fig. 3 F) as well as junctional 
phospho-PAK staining (not depicted). Taken together, these 
data show that matrix-specifi  c PAK activation triggered by onset 
of fl  ow or prolonged disturbed fl  ow mediates enhanced endo-
thelial monolayer permeability. 
Flow stimulates PAK-dependent 
paracellular pore formation
Multiple growth factors and other bioactive substances use a 
pathway in which PAK regulates phosphorylation of MLCK to 
increase cellular contractility, thereby inducing endothelial cell 
permeability through formation of paracellular pores (Stockton 
et al., 2004). To test whether fl  ow induces PAK-dependent para-
cellular pores, BAE cells were treated with either the control or 
Figure 1.  Flow stimulates matrix-speciﬁ  c PAK phosphorylation. (A) BAE 
cells plated on MG or FN for 4 h were sheared for the indicated times. 
Phosphorylation of PAK on Ser141 was assessed by immunoblotting total 
cell lysates with a phosphorylation site–speciﬁ  c antibody. Values are means ± 
SD normalized for total PAK (n = 3–4). Representative blots are shown. 
(B) Endothelial cells plated on FN were sheared for 15 min or kept under 
static conditions, and PAK phospho-Ser141 localization was assessed by 
immunocytochemistry. Representative images are shown. (C) Shear stress 
ﬂ  ow proﬁ  les for the CCA and the ICS were determined using MRI-generated 
near-wall velocity gradient proﬁ  les of normal carotid arteries. (D) Endo-
thelial cells on FN were stimulated for 24 h with either CCA or ICS ﬂ  ow. 
Phosphorylation of PAK on Ser141 normalized to total PAK was assessed 
as described in A. Values are means ± SD after normalization for total 
protein (n = 3). *, P < 0.05.
Figure 2.  Onset of ﬂ  ow stimulates endothelial leak. (A) To monitor ﬂ  ow-
induced permeability, we used large transwell membranes mounted into a 
modiﬁ  ed cone and plate viscometer and subjected to shear stress. HRP was 
infused into the top well for 1 h, and permeability was assessed by measur-
ing ﬁ  nal HRP activity in the bottom well media. (B) BAE cell monolayers 
were stimulated with acute onset of ﬂ  ow, and the permeability response 
was measured as described in A during both the ﬁ  rst and fourth hour after 
application of ﬂ  ow. Values are means ± SD (n = 3). *, P < 0.05.JCB • VOLUME 176 • NUMBER 5 • 2007  722
PAK-Nck inhibitory peptide, sheared for 30 min, and assayed 
for the presence of paracellular pores by staining for the adher-
ens junction protein β-catenin. Flow induced the formation of 
paracellular pores, which was strongly reduced by the pretreat-
ment with the PAK-Nck inhibitory peptide (Fig. 4).
Effects of cytokines and oxidized 
LDL (oxLDL)
Although fl  ow patterns regulate susceptibility to atherosclerosis, 
a number of soluble factors also promote atherosclerotic plaque 
development and likely contribute to endothelial permeability 
in atherosclerosis. OxLDL stimulates endothelial cell permea-
bility through a Rho-dependent pathway (Essler et al., 1999; 
Siess et al., 1999). In early atherogenesis, activated endothelial 
cells and macrophages produce MCP-1, which also stimulates 
endothelial permeability (Stamatovic et al., 2003), as do the 
 macrophage-derived  cytokines  TNFα and IL-1β (Martin et al., 
1988; Brett et al., 1989). Furthermore, mice defi  cient in either 
MCP-1 or TNFα show reduced atherosclerosis (Gu et al., 1998; 
Ohta et al., 2005). We previously showed that TNFα-induced 
endothelial permeability was reduced by the PAK-Nck inhibi-
tory peptide (Stockton et al., 2004). To analyze the matrix 
dependence of these factors, PAK phosphorylation was assessed 
in endothelial cells plated on FN or MG. Though the time courses 
were distinct, MCP-1, TNFα, and oxLDL stimulated PAK phos-
phorylation in cells on FN but not on MG (Fig. 5). In all cases, 
phosphorylated PAK localized to cell–cell junctions, and this 
  localization was inhibited by the Pak-Nck peptide (Fig. S3, avail  able 
at http://www.jcb.org/cgi/content/full/jcb.200609008/DC1).
Figure 3.  Flow-induced endothelial permeability is matrix and PAK 
  dependent. (A) BAE cells plated on transwell membranes coated with col-
lagen IV, MG, or FN were stimulated with laminar ﬂ  ow at 12 dynes/cm
2. 
HRP leak across the membrane was assessed during the ﬁ  rst hour of ﬂ  ow; 
data are presented as absolute solute permeability as described in Mate-
rials and methods. Values are means ± SD (n = 3). (B) Endothelial cells 
were plated on transwells coated with MG and increasing concentrations 
of FN, stimulated with 12 dynes/cm
2 laminar ﬂ  ow for 1 h, and HRP leak 
across the membrane was assessed. Values are means ± SD (n = 3). 
(C) Endothelial cells plated on FN-coated transwell membranes were 
treated with either control peptide or PAK-Nck inhibitory peptide (20 μg/ml 
for 1 h). HRP leak across the membrane was assessed during the ﬁ  rst hour 
of steady laminar ﬂ  ow at 12 dynes/cm
2. Values are means ± SD (n = 4). 
(D) Endothelial cells plated on FN-coated transwell membranes were 
transfected with HA-tagged PAK AID. At 24 h after transfection, mono-
layers were exposed to ﬂ  ow, and HRP leak across the membrane was as-
sessed during the ﬁ  rst hour. Values are means ± SD (n = 3). Transfection 
efﬁ   ciency ranged from  35 to  50% as determined by immunocyto-
chemistry. (E) Endothelial cells plated on FN-coated transwell membranes 
were treated with either control or PAK-Nck inhibitory peptide (20 μg/ml 
for 1 h). Alexa 488–conjugated BSA leak across the membrane was 
  assessed during the ﬁ  rst hour of steady laminar ﬂ  ow at 12 dynes/cm
2. 
Data (means ± SD; n = 3) are shown as absolute solute permeability. 
(F) Endothelial cells plated on FN-coated transwell membranes were stimu-
lated for 4 h with CCA or ICS ﬂ  ow. HRP leak across the membrane was 
assessed during the last 1-h period. Some cells were pretreated with 
the PAK-Nck inhibitory peptide (20 μg/ml for 1 h) and stimulated with 
ICS ﬂ  ow in the continued presence of the peptide. Values are means ± 
SD (n = 3).
Figure 4.  Flow stimulates PAK-dependent formation of paracellular pores. 
BAE cells plated on FN were treated with either control or PAK-Nck inhibi-
tory peptide (20 μg/ml for 1 h) and stimulated with ﬂ  ow for 30 min, and 
cell–cell junctions were visualized by staining for β-catenin. (A) Representa-
tive β-catenin stains are shown. Arrows indicate the presence of a para-
cellular pore. (B) The total number of paracellular pores per high power 
ﬁ  eld was determined. 20 ﬁ  elds were counted per experiment (n = 3).PAK MEDIATES PERMEABILITY IN ATHEROSCLEROSIS • ORR ET AL. 723
We next examined monolayer permeability. All of these 
factors triggered matrix-dependent increases in permeability 
(Fig. 6 A) that were inhibited by the PAK-Nck blocking peptide 
(Fig. 6 B) and by expression of the PAK AID (Fig. 6 C). Thus, 
effects of a number of atherogenic soluble factors on PAK-
dependent permeability are strongly modulated by the ECM.
PAK is phosphorylated in vivo
Areas of disturbed fl  ow in vivo show elevated endothelial cell 
permeability (Himburg et al., 2004; LaMack et al., 2005). These 
regions also show deposition of FN in the subendothelial ECM 
and expression of intercellular adhesion molecule 1 (ICAM-1) 
and vascular cell adhesion molecule (VCAM-1; Orr et al., 
2005). We therefore tested whether permeability, PAK activity, 
and FN correlate in vivo. The carotid arteries from young 
(20-wk-old) ApoE
−/− mice fed either a chow or Western diet were 
isolated and processed for immunohistochemistry. In mice on a 
chow diet, the carotid sinus displayed some monocyte  infi  ltration 
but no foam cell formation. PAK phosphorylation was observed 
specifi  cally in the atherosclerosis-prone region of these vessels 
but not nearby athero-resistant regions (Fig. 7 A). Nearby sections 
showed FN in the subendothelial matrix in the same regions of 
the artery (Fig. 7 A). Furthermore, enhanced expression of 
VCAM-1 was detected in these regions, indicating endothelial 
activation. The opposite side of the carotid sinus can develop 
atherosclerosis in some cases but in this mouse shows no FN, 
VCAM-1, or phospho-PAK staining (Fig. 7 B). PAK phosphor-
ylation, VCAM-1, and FN were all enhanced by the Western 
diet within the carotid sinus (Fig. 7 C) but not in athero-resistant 
regions of the CCA (Fig. 7 D). Monocytes recruited to athero-
prone regions of arteries from these mice also stained positively 
for phospho-PAK. Thus, PAK activation correlates with sub-
endothelial FN and infl  ammatory markers.
To determine whether active PAK localizes to cell–cell 
junctions in atherosclerosis in vivo, aortas from ApoE
−/− mice 
on a chow diet were fi  xed, excised, and examined en face. 
  Staining for platelet-endothelial cell adhesion molecule 1 
(PECAM-1) confi  rmed the ability to visualize endothelial cell 
Figure 5.  PAK activation by multiple atherogenic stimuli is matrix dependent. 
BAE cells plated on MG or FN for 4 h were treated with MCP-1 at 
50 ng/ml (A), TNFα at 10 ng/ml (B), or oxLDL at 100 μg/ml (C) for the indi-
cated times. Phosphorylation of PAK on Ser141 was assessed by immuno-
blotting total cell lysates with a phosphorylation site–speciﬁ  c  antibody. 
Values are means ± SD after normalization for total PAK (n = 3–4). *, P < 
0.05; **, P < 0.01.
Figure 6. Matrix-speciﬁ   c PAK activation stimulates permeability in 
  response to multiple atherogenic stimuli. (A) Endothelial cells plated on 
trans  well membranes coated with either MG or FN were stimulated with 
50 ng/ml MCP-1, 10 ng/ml TNFα, or 100 μg/ml oxLDL for 2 h, and the 
HRP leak across the membrane was assessed. Values are means ± SD 
(n = 3–4). (B) BAE cells plated on FN-coated transwell membranes were 
treated with either a control or a PAK-Nck inhibitory peptide (20 μg/ml 
for 1 h). Monolayers were stimulated with MCP-1, TNFα, or oxLDL for 
2 h, and the HRP leak across the membrane was assessed. Values are 
means ± SD (n = 3). (C) Endothelial cells plated on FN-coated transwell 
membranes were transfected with HA-tagged PAK AID. After 24 h, mono-
layers were stimulated with MCP-1, TNFα, or oxLDL for 2 h, and the 
HRP leak across the membrane was assessed. Values are means ± SD 
(n = 3). Transfection efﬁ  ciency ranged from  35 to  50% as determined 
by immunocytochemistry.JCB • VOLUME 176 • NUMBER 5 • 2007  724
junctions in vivo and illustrated endothelial cell alignment in an 
athero-protected region of the ascending aortic arch  (unpublished 
data). Although athero-resistant regions of the aorta showed no 
staining, athero-prone regions of the lesser curvature of the arch 
showed focal areas of high phospho-PAK staining at cell–cell 
junctions (Fig. 7 E).
PAK inhibition reduces permeability 
in atherosclerosis in vivo
To determine whether PAK is responsible for the increased 
  permeability during development of atherosclerosis, 32-wk-old 
ApoE
−/− mice (chow diet) were given intraperitoneal injections 
of the PAK-Nck blocking peptide or a control peptide. Mice 
  under these conditions are reported to develop moderate athero-
sclerotic lesions, though plaque development is slower than 
in animals on a high-fat Western diet (Reddick et al., 1994). 
Vascular permeability within the aorta was then assessed by 
measuring leakage of Evans blue dye into the vascular wall. 
Aortas from C57Bl/6 mice were used as a source for healthy, 
atherosclerosis-free vessels. Each mouse received 1 mg of pep-
tide at 24 h and 1 h before Evans blue injection via the tail 
vein. After 30 min, leakage of dye into the aorta was assessed. 
Although little Evans blue accumulated in the aorta of C57Bl/6 
mice, in ApoE
−/− mice, dye was apparent at the lesser curvature 
of the arch and at branch points for major arteries in both the 
nontreated and control peptide–treated animals (Fig. 8), consis-
tent with known athero-prone regions. The Pak-Nck peptide 
  inhibited 67% of the increase in permeability, relative to healthy 
vessels. These data suggest that PAK makes an important con-
tribution to permeability in atherogenesis.
Discussion
These data support the concept that remodeling of the subendo-
thelial ECM plays a crucial role in atherogenesis. Previous work 
demonstrated a correlation between enhanced vascular permea-
bility and atherosclerosis (Ogunrinade et al., 2002). In this 
work, we present evidence for ECM-specifi  c activation of PAK 
by atherogenic stimuli, leading to increased permeability. PAK 
activation may be initiated by disturbed fl  ow, though as athero-
sclerosis develops, soluble factors such as oxLDL and cytokines 
produced by immune cells and activated endothelium most 
likely make major contributions. Importantly, PAK activation at 
athero-prone sites in vivo correlates with areas of FN  deposition. 
Finally, inhibiting PAK function in vivo reduced permeability in 
athero-prone regions.
The mechanisms regulating the matrix specifi  city of PAK 
activation are presently unclear. Flow-induced Rac activation is 
equivalent on all matrices (unpublished data), suggesting that 
there may be matrix-specifi  c signals that inhibit PAK activation. 
Known mechanisms limiting PAK activation include binding 
of PAK to Nischarin or hPIP1 and dephosphorylation by the 
phosphatases PP2A and POPX1/2 (Xia et al., 2001; Koh et al., 
2002; Kumar and Vadlamudi, 2002; Alahari et al., 2004). Phos-
phorylation of PAK by protein kinase A also inhibits PAK 
activation (Howe and Juliano, 2000). Further examination of 
matrix-specifi  c PAK activation will be an interesting avenue for 
future work.
The current data suggest that reducing either PAK acti-
vation or localization to cell–cell junctions should reduce the 
permeability of the endothelial cell layer. Recently, the Ser/Thr 
kinases Akt and protein kinase G (PKG) were found to phos-
phorylate PAK at Ser21 within the Nck-binding sequence, inhib-
iting the interaction between PAK and Nck  (Zhou et al., 2003; 
Fryer et al., 2006). Because blocking the PAK–Nck interaction 
inhibits localization of PAK to cell–cell borders and decreases 
endothelial permeability, these kinases might decrease perme-
ability in a similar manner. Indeed, both Akt and cyclic GMP/
PKG can decrease vascular permeability (Pearse et al., 2003; 
Chen et al., 2005; Moldobaeva et al., 2006). Whether PAK is the 
relevant target for these effects remains to be explored.
The mechanisms by which permeability is elevated in the 
plaque endothelium are not well understood. Dissolution of 
  intercellular interactions during endothelial cell division and 
apoptosis, both of which are elevated at athero-prone sites in vivo 
(Weinbaum et al., 1985; Lin et al., 1988), has been suggested as 
Figure 7.  PAK activation and FN deposition in vivo. Male ApoE
−/− mice 
fed a chow diet (A and B) or a Western diet (C and D) for 10 wk were 
killed, and the carotid arteries were removed and embedded in parafﬁ  n. 
Nearby sections were stained for PAK phospho-Ser141, FN, and VCAM-1, 
and shown at high magniﬁ  cation (40×) with lower magniﬁ  cation (10×) 
views of the entire vessels shown as insets. A and B show different areas of 
the same carotid sinus, and C and D show the carotid sinus and CCA, 
  respectively, from the same animal. A 3D representation of the artery indi-
cates the location of the sections. Bars: 50 μm; (insets) 200 μm. (E) Male 
ApoE
−/− mice fed a chow diet for 10 wk were killed, the aortic arch was 
excised, and en face staining was performed for PAK phospho-Ser141. 
Representative images are shown at both 20× and 40× magniﬁ  cations. 
Bars: (left) 200 μm; (right) 100 μm.PAK MEDIATES PERMEABILITY IN ATHEROSCLEROSIS • ORR ET AL. 725
a possible mechanism. However, the correlation between endo-
thelial cell turnover and enhanced permeability in vivo is weak 
(Penn and Chisolm, 1991; Malinauskas et al., 1995). A more 
likely mechanism involves TJs in athero-prone regions, which 
are discontinuous compared with athero-resistant regions 
(Okano and Yoshida, 1994). Changes in TJ protein expression, 
phosphorylation, and reorganization could all contribute to 
  decreased barrier function (Ogunrinade et al., 2002). Both fl  ow 
and cytokines induce permeability too rapidly for changes in 
gene expression to be an attractive mechanism. Shear stress 
stimulates occludin phosphorylation on Ser/Thr residues, which 
could alter occludin localization to TJs or function (Sakakibara 
et al., 1997; DeMaio et al., 2001). VEGF stimulates PAK-
  dependent VE-cadherin phosphorylation, resulting in its arrestin-
dependent internalization and the formation of paracellular 
pores (Gavard and Gutkind, 2006). Myosin light chain phos-
phorylation triggers cell contraction and the formation of para-
cellular pores (Stockton et al., 2004), and contractility appears 
to be a common pathway for endothelial cell permeability by 
multiple atherogenic stimuli (Takeya et al., 1993; Essler et al., 
1999; Siess et al., 1999; Ogunrinade et al., 2002; Stamatovic 
et al., 2003). PAK inhibition decreases myosin phosphorylation 
and contractility in endothelial cells (Kiosses et al., 1999; 
Stockton et al., 2004). Thus, effects of PAK on the cytoskeleton 
appear to be involved in regulation of permeability, though other 
events, such as VE-cadherin and occludin phosphorylation, are 
likely to contribute.
PAK regulates cytoskeletal organization, proliferation, 
and movement in many cell types, making PAK activity by 
  itself an unlikely target for long term therapy. For example, PAK 
inhibition in mice with a cell-permeable peptide was recently 
shown to mimic Alzheimer’s disease (Zhao et al., 2006). However, 
specifi  c interactions, such as Nck, may offer more attractive 
therapeutic targets. The ECM dependence of PAK activity may 
provide an especially attractive means for therapeutic inter-
vention that would be less perturbing than global inhibition of 
kinase activity.
Materials and methods
Cell culture, transfection, and shear stress
BAE cells (a gift from H. Sage, Hope Heart Institute, Seattle, WA) were 
maintained in low-glucose DME containing 10% calf serum (CS), 10 U/ml 
penicillin, and 10 μg/ml streptomycin (Invitrogen). Cells were plated for 
4–24 h on 38- × 75-mm
2 glass slides (Corning) precoated with collagen 
IV (20 μg/ml in PBS; Sigma-Aldrich), MG (1:100 dilution in serum-free 
media; Calbiochem), or FN (10 μg/ml in PBS). After 4 h, cells were fully 
attached and spread and formed a conﬂ  uent monolayer. Slides were then 
loaded onto a parallel plate ﬂ  ow chamber in 0.5% CS, and 12 dynes/cm
2 
shear stress was applied for varying times as previously described (Orr 
et al., 2005). To stimulate BAE cells with athero-prone (ICS) or athero-
  protective (CCA) shear stress proﬁ  les, BAE cells were plated as described 
except in a custom Petri dish and stimulated as previously described (Blackman 
et al., 2002). Human hemodynamic shear stress proﬁ  les were developed 
from MRI-generated near-wall velocity proﬁ  les of normal carotid arteries 
(Gelfand et al., 2006). Transient transfection of HA-tagged PAK AID was 
accomplished by Effectene (QIAGEN) using the manufacturer’s protocols.
Immunoblotting and immunocytochemistry
Cell lysis and immunoblotting were performed as previously described 
(Orr et al., 2002). Antibodies used include rabbit anti–phospho-PAK 
(Ser141; 1:5,000; Biosource International) and rabbit anti-PAK (1:1,000; 
Cell Signaling Technologies). For immunocytochemistry, cells were ﬁ  xed 
with PBS containing 2% formaldehyde, permeabilized with 0.2% Triton 
X-100, and blocked for 1 h in PBS containing 1% BSA and 10% goat serum. 
  Primary antibodies were incubated with cells in blocking buffer as follows: 
rabbit anti–phospho-PAK (Ser141; 1:500 overnight), rabbit anti–β-catenin 
(1:200 overnight; Santa Cruz Biotechnology, Inc.), and mouse anti–ZO-1 
(1:500 overnight). Cells were then incubated in 1 μg/ml Alexa 488–
conjugated goat anti–rabbit IgG or goat anti–mouse IgG (Invitrogen). 
Slides were mounted with Fluoromount G, and images were taken using the 
60× oil-immersion objective on a microscope (DiaPhot; Nikon) equipped 
with a video camera (CoolSnap; Photometrics) using the Inovision ISEE 
software program.
Permeability assays
A novel transwell well-ﬂ  ow device was developed to assay macromolecule 
permeability across an intact endothelial monolayer using previously es-
tablished methods (Stockton et al., 2004). In brief, a previously developed 
cone-and-plate ﬂ  ow device was adapted to accept a 75-mm chamber trans-
well insert (Blackman et al., 2002). Custom ﬂ  anges mounted on the lip of 
the Petri dish hold inlet and outlet tubing for the top and lower chambers, 
respectively, to inject and remove HRP without interrupting ﬂ  ow. Transwell 
chambers (3.0-μm pore size; Costar) were coated with either MG or FN, 
and BAE cells were allowed to attach for 4–24 h. Some transwells were 
coated with a ﬁ  xed concentration of MG followed by increasing concen-
trations of FN. For ﬂ  ow experiments, cells on 75-mm chambers were serum 
deprived for 4 h in phenol red-free DME containing 0.5% CS and 2% dex-
tran (wt/vol) and loaded onto the ﬂ  ow device stage, and shear stress was 
applied using the modiﬁ  ed cone-and-plate device. At desired times, the 
medium was replaced with fresh medium containing 60 μg/ml HRP 
(Sigma-Aldrich) or Alexa 488–conjugated BSA (Invitrogen). After 1 h, 
  medium was removed from the lower chamber, and cells were ﬁ  xed in 2% 
formaldehyde and stained with Coomassie blue to detect cell loss or exam-
ined by immunocytochemistry for Ser141 phosphorylated PAK. For cyto-
kine and LDL-induced permeability assays, cells grown on 6.5-mm ﬁ  lters 
were serum deprived for 4 h in phenol red–free DME containing 0.5% CS 
and transferred to fresh medium containing soluble factors for 90 min. HRP 
was then added to the top well to give a ﬁ  nal concentration of 60 μg/ml. 
After 30 min, medium from the bottom well was removed, incubated with 
0.5 mM guaiacol, 50 mM Na2HPO4, and 0.6 mM H2O2, and formation of 
O-phenylenediamine was determined by measure of absorbance at 470 nm. 
Alexa 488–conjugated BSA was measured using a spectroﬂ  uorometer 
(FluoroLog; Jobin Yvon). Results are shown as a fold increase in HRP activ-
ity or in absolute solute permeability. Solute permeability coefﬁ  cients for 
the endothelial monolayer were calculated as Ps = ∆CaVa/∆C∆tS, where 
Figure 8.  PAK inhibition reduces permeability in vivo. C57Bl/6 and 
ApoE
−/− mice fed a chow diet were treated with PAK-Nck inhibitory or 
control peptides, and leakage of Evans blue dye into the aortas was 
assessed as described in Materials and methods. Images were recorded 
by bright ﬁ   eld microscopy. Results were quantiﬁ   ed by extracting the 
dye and measuring absorbance at 620 nm. Values were normalized to 
the dry weight of the aorta (n = 3). *, P < 0.05. Representative images 
are shown.JCB • VOLUME 176 • NUMBER 5 • 2007  726
∆Ca is the ﬁ  nal concentration in the lower well, Va is the volume of the 
  bottom well (ml), ∆C is the concentration in the top well, ∆t is the sampling 
  interval (s), and S is the surface area of the transwell (cm
2; Kajimura 
et al., 1997).
Animals and vessel harvest
Nine male ApoE-deﬁ   cient mice on a C57Bl/6 background from The 
  Jackson Laboratory, 8–12 wk of age and weighing 18–20 g, were used 
in these experiments. Four mice were fed a Western-type atherogenic diet 
(TD 88137 [Harlan-Teklad]; containing 21% fat by weight, 0.15% by 
weight cholesterol, and 19.5% by weight casein without sodium cholate) 
for 10 wk before sacriﬁ  ce. Control mice were fed a chow diet during this 
time. At 20 wk of age (10 wk on diet), mice were perfused with 4% para-
formaldehyde, and the aortic arch, left carotid sinus, and right carotid 
  sinus were processed for parafﬁ  n embedding. For Evans blue assays, six 
male C57Bl/6 and nine male ApoE-deﬁ  cient mice (The Jackson Laboratory) 
were maintained on chow diets for 8 or 32 wk, respectively.
Immunohistochemistry
5-μm parafﬁ  n sections were obtained for immunohistochemistry. Immuno-
histochemistry for adhesion molecules VCAM-1 (Santa Cruz Biotechnol-
ogy, Inc.) was performed as previously described (McPherson et al., 
2001). After microwave antigen retrieval with antigen unmasking solution 
(Vector Laboratories), rabbit anti-FN (1:400; Sigma-Aldrich) and rabbit 
anti-Ser141 phosphorylated PAK (1:250) were applied. Detection of anti-
bodies was with Vetastain Elite kit (Vector Laboratories). Visualization was 
with diaminobenzidine (DakoCytomation). For en face staining, the aortic 
arch was cut into rings and stained for either PECAM-1 or Ser141 phos-
phorylated PAK using Alexa 488–conjugated goat anti–rabbit secondary 
antibodies to detect localization. Rings were then cut, opened, and 
mounted between two coverslips for en face viewing by ﬂ  uorescence 
  microscopy. Images were acquired using the 10× or 40× objective on a 
microscope (BX51; Olympus) equipped with a digital camera (DP70; 
Olympus) using ImagePro Plus software (Media Cybernetics).
Permeability to Evans blue in vivo
Mice were injected intraperitoneally with 0.1 ml of either control peptide 
or the PAK-Nck inhibitory peptide (10 mg/ml) at 24 h and at 1 h before 
Evans blue injection. Evans blue (0.1 ml of 1% dye in PBS) was injected 
into the tail vein. After 30 min, mice were killed with ketamine/xylazine 
and perfused through the left ventricle with 10 ml of 4% formaldehyde in 
PBS, and the aorta was excised from the cusp to the renal artery branches. 
Bright ﬁ  eld microscopy of excised aortas was performed using the 0.5 and 
1.2× objectives on a microscope (SZX12; Olympus) equipped with a 
DP70 digital camera using ImagePro Plus. Aortas were dried and weighed, 
Evans blue was extracted by incubation in formamide for 24 h at 60°C, 
and absorbance at 620 nm was determined. Concentration curves for 
pure Evans blue were used to calculate the total amount of dye extracted, 
and this value was normalized to the weight of the isolated aortas.
Online supplemental material
Independent of matrix composition, the 4-h plating time is sufﬁ  cient to 
  allow both adherens and TJ formation, as assessed by staining cells for 
β-catenin and ZO-1, respectively (Fig. S1). Matrix-speciﬁ  c effects on 
  monolayer permeability are not due to differences in matrix permeability, 
which shows no difference between MG and FN (Fig. S2). Localization to 
cell–cell junctions is required for PAK-dependent permeability (Stockton 
et al., 2004), and TNFα, MCP-1, and oxLDL all stimulate active PAK localiza-
tion to cell–cell junctions, which was abrogated by the addition of the PAK-
Nck inhibitory peptide (Fig. S3). Online supplemental material is available 
at http://www.jcb.org/cgi/content/full/jcb.200609008/DC1.
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